Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Location
New Haven, CT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % -20%
Debt-to-equity 154 % +2.7%
Return On Equity -390 % -73.2%
Return On Assets -153 % +3.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105,855,155 shares +4.7%
Common Stock, Shares, Outstanding 105,803,655 shares +11.5%
Entity Public Float 2,239,000,000 USD +1.3%
Common Stock, Value, Issued 1,743,740,000 USD +26.2%
Weighted Average Number of Shares Outstanding, Basic 105,815,038 shares +12.1%
Weighted Average Number of Shares Outstanding, Diluted 105,815,038 shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 680,593,000 USD -10.8%
General and Administrative Expense 111,982,000 USD +30.7%
Costs and Expenses 792,575,000 USD -6.6%
Operating Income (Loss) -792,575,000 USD +6.6%
Nonoperating Income (Expense) 13,604,000 USD -69.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -778,971,000 USD +3.2%
Income Tax Expense (Benefit) 1,139,000 USD
Net Income (Loss) Attributable to Parent -780,110,000 USD +3%
Earnings Per Share, Basic -7 USD/shares +20.5%
Earnings Per Share, Diluted -7 USD/shares +20.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 184,847,000 USD +1.2%
Marketable Securities, Current 75,370,000 USD -74.4%
Other Assets, Current 8,415,000 USD +6%
Assets, Current 323,615,000 USD -26.5%
Property, Plant and Equipment, Net 17,521,000 USD -4.1%
Operating Lease, Right-of-Use Asset 45,201,000 USD +56.4%
Intangible Assets, Net (Excluding Goodwill) 18,400,000 USD 0%
Goodwill 1,390,000 USD 0%
Other Assets, Noncurrent 48,197,000 USD +50.8%
Assets 409,123,000 USD -19.9%
Accounts Payable, Current 17,491,000 USD -11.4%
Employee-related Liabilities, Current 18,197,000 USD +14.6%
Accrued Liabilities, Current 73,522,000 USD +15.7%
Liabilities, Current 113,023,000 USD -25.8%
Operating Lease, Liability, Noncurrent 40,394,000 USD +59.6%
Other Liabilities, Noncurrent 4,596,000 USD +0.11%
Liabilities 426,283,000 USD +1.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 36,000 USD -74.3%
Retained Earnings (Accumulated Deficit) -1,938,981,000 USD -67.3%
Stockholders' Equity Attributable to Parent -17,160,000 USD -1.1%
Liabilities and Equity 409,123,000 USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -165,124,000 USD -60.9%
Net Cash Provided by (Used in) Financing Activities 369,000 USD -89.2%
Net Cash Provided by (Used in) Investing Activities 164,879,000 USD +3.8%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 105,803,655 shares +11.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 147,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 188,384,000 USD +1.1%
Deferred Tax Assets, Valuation Allowance 303,731,000 USD +17.1%
Operating Lease, Liability 36,584,000 USD +18.5%
Depreciation 4,185,000 USD +8.3%
Payments to Acquire Property, Plant, and Equipment 461,000 USD +4.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -780,214,000 USD +3%
Lessee, Operating Lease, Liability, to be Paid 49,304,000 USD +23.9%
Operating Lease, Liability, Current 5,512,000 USD +49.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6,183,000 USD +29.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 6,135,000 USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12,720,000 USD +42.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5,844,000 USD +19.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 2,300,000 USD +4.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5,325,000 USD +18.1%
Additional Paid in Capital 178,045,000 USD +91.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2,246,000 USD +55.3%
Deferred Tax Assets, Net of Valuation Allowance 8,418,000 USD +11.9%